Delisting risk
VivoSim Labs (VIVS)
Preclinical liver and intestinal toxicology testing with primary human tissue models.
$0.2800
Pre-market+0.00 (+0.07%)
At close$0.2798(+0.39%)
Something off on this page? Send us feedback.
Next report
Nov 5, 2026
in 63 days
EPS estimate
—
Revenue estimate
—
Fiscal quarter
Q2 FY27
EPSReportedEstimate
Nov '24May '25Aug '25Nov '25Feb '26Jul '26Aug '26Nov '26
Reported−$0.14−$3.48−$1.14−$0.98−$1.03−$2.21−$0.25Pending
Estimate−$0.26−$2.28—−$2.28−$2.40−$2.04——
Surprise+46.2%−52.6%—+57.0%+57.1%−8.3%——
RevenueReportedEstimate
Nov '24May '25Aug '25Nov '25Feb '26Jul '26Aug '26Nov '26
Reported$30.0K$51.0K$37.0K$28.0K$26.0K$40.0K$18.0KPending
Estimate———$50.0K$50.0K$54.0K——
Surprise———−44.0%−48.0%−25.9%——
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | — | — | — |
| Aug 2026 | — | −$0.25 | — |
| Aug 2026 | — | — | — |
| Jul 2026 | −$2.04 | −$2.21 | −8.3% |
| May 2026 | −$2.04 | — | — |
| Feb 2026 | −$2.40 | −$1.03 | +57.1% |
| Nov 2025 | −$2.28 | −$0.98 | +57.0% |
The latest year is open to everyone — the 39 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Nov 2024 | |||
| Jun 2024 | |||
| Mar 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | — | — | — | — | — | — | — |
| Aug 12, 2026 | — | −$0.25 | — | — | $18.0K | — | −5.8% |
| Aug 6, 2026 | — | — | — | — | — | — | — |
| Jul 14, 2026 | −$2.04 | −$2.21 | −8.3% | $54.0K | $40.0K | −25.9% | +2.2% |
| May 29, 2026 | −$2.04 | — | — | $54.0K | — | — | — |
| Feb 11, 2026 | −$2.40 | −$1.03 | +57.1% | $50.0K | $26.0K | −48.0% | −0.5% |
| Nov 6, 2025 | −$2.28 | −$0.98 | +57.0% | $50.0K | $28.0K | −44.0% | −0.5% |
The latest year is open to everyone — the 39 quarters behind it read with an account. Sign in | |||||||
| Aug 12, 2025 | |||||||
| May 30, 2025 | |||||||
| Nov 8, 2024 | |||||||
| Jun 30, 2024 | |||||||
| Mar 31, 2024 | |||||||
| Dec 31, 2023 | |||||||
| Sep 30, 2023 | |||||||
| Jun 30, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Sep 30, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||